(CercleFinance.com) – Noxxon Pharma announces today that it has drawn additional tranches of financing from its financing agreement with Atlas Special Opportunities (ASO), for a total amount of 2,375,000 euros and issued 2,419 convertible bonds of a nominal value of 1,000 euros each.
The remaining availability under the agreement with ASO extends the company’s financial visibility through December 2022, Noxxon reported.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
